NSEShareholders meeting15 Jul 2026 · 15 Jul 2026, 06:52 pm
Shareholders meeting
Bliss GVS Pharma Limited · BLISSGVS
✦ AI SummaryResults
Bliss GVS Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 15, 2026, and informed the Exchange regarding voting results. The company has declared a 100% final dividend of ₹ 1.00 per equity share for the financial year ended March 31, 2026, and re-appointed Mr. Narsimha Shibroor Kamath as a Managing Director & CEO.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bliss GVS Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 15, 2026. Further, the company has informed the Exchange regarding voting results.